USDA deregulation

Get the latest USDA deregulation news, policy changes and regulatory developments affecting agriculture in the United States. Coverage examines decisions by the US Department of Agriculture (USDA) on genetically engineered crops, agricultural biotechnology, plant health, seed development and the regulation of emerging farming technologies. These decisions can influence research requirements, product development timelines, commercialisation and compliance obligations for agricultural businesses.

A key area is the regulation of genetically engineered plants by the USDA’s Animal and Plant Health Inspection Service (APHIS). Regulatory changes may involve exemptions, risk assessments, permitting requirements and the conditions under which certain biotechnology products can be developed or cultivated without additional oversight under specific federal rules. Developments involving genome editing, genetically modified crops, disease-resistant plants and new crop varieties are relevant to seed companies, biotechnology developers, universities and farmers. The scope of regulatory requirements depends on the technology used, the characteristics of the resulting plant and the applicable rules.

Find updates on USDA regulatory decisions, proposed rule changes, public consultations, field-trial authorisations and legal challenges involving agricultural biotechnology. Coverage also examines the implications of deregulation for crop innovation, environmental assessments, plant pest risks, agricultural trade and industry investment. These developments provide insight into the changing regulatory landscape for biotechnology and its potential effects on US agriculture.